Menu
Surgical Intervention
Minor Clinic Intervention
Minor Clinic Intervention Invasive Day Surgery / Outpatient

Tissue Expander Insertion

Protocol / Details

The procedure involves creating a surgical pocket in the sub-muscular or subcutaneous plane to accommodate a tissue expander. After local infiltration of lidocaine/epinephrine, an incision is made, and the pocket is dissected to the appropriate size. The expander is inserted, the fill port is secured if remote, and the wound is closed in layers with absorbable sutures. This is a sterile outpatient procedure performed under local anesthesia.

Procedure Type
Surgery / Invasive
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Obtain informed consent, verify patient allergies, perform a site assessment, ensure the patient is fasting only if sedation is used, and conduct a physical examination of the target skin area to ensure no active infection is present.

Immediate discharge post-procedure. Keep the wound clean and dry for 48 hours. Monitor for signs of infection (redness, pus, fever). The patient is scheduled for the first expansion session after 1-2 weeks once healing is confirmed.

Comprehensive Clinical Guide: Tissue Expander Insertion

1. Introduction and Clinical Overview

Tissue expansion is a reconstructive surgical technique that allows the body to "grow" extra skin by utilizing the biological process of mechanical creep and biological stretch. The procedure involves the insertion of a silicone balloon (the tissue expander) beneath the skin and subcutaneous tissue adjacent to a deficit area. Over a period of weeks or months, the device is gradually inflated with sterile saline, stimulating the surrounding tissue to expand.

This technique is a cornerstone of modern reconstructive surgery because it produces "like-with-like" tissue—meaning the expanded skin matches the color, texture, thickness, and hair-bearing qualities of the surrounding area, resulting in superior aesthetic and functional outcomes compared to free flaps or skin grafts.


2. Technical Specifications and Mechanisms of Action

The tissue expander consists of three primary components:
1. The Envelope: A high-strength, medical-grade silicone elastomer shell.
2. The Valve/Port: A self-sealing injection port, either integrated into the device or remote (connected via tubing), used for percutaneous saline injections.
3. The Filling Medium: Sterile 0.9% Normal Saline.

The Biological Mechanism

When the expander is inflated, it exerts mechanical stress on the overlying skin. This triggers several physiological responses:
* Mechanical Creep: Immediate displacement of fluid from the dermis and subcutaneous space.
* Stress Relaxation: A time-dependent decrease in force required to maintain a given level of stretch.
* Biological Stretch (Hyperplasia): Sustained tension stimulates mitosis in the basal layer of the epidermis and increases collagen synthesis in the dermis, effectively increasing the total surface area of the skin.
* Angiogenesis: Increased vascularity occurs within the expanded flap, ensuring the viability of the tissue for subsequent transposition.


3. Extensive Clinical Indications and Usage

Tissue expansion is indicated when the surrounding skin is insufficient for direct closure or when the donor site for a flap is unavailable or undesirable.

Clinical Condition Primary Indication
Post-Mastectomy Breast reconstruction (two-stage: expander then implant).
Burn Scar Alopecia Expanding hair-bearing scalp to cover scarred, hairless areas.
Congenital Nevi Gradual removal of large, pigmented lesions.
Traumatic Scars Replacing large, contracted scar tissue with healthy skin.
Pediatric Reconstruction Correcting congenital deformities without donor site morbidity.

4. Patient Pre-Operative Preparation

A successful outcome begins with rigorous patient selection and preparation.

  • Medical Clearance: Evaluation of comorbidities (diabetes, smoking, autoimmune disorders). Smoking must be ceased at least 4-6 weeks pre-operatively to minimize the risk of skin necrosis.
  • Anatomic Mapping: Surgeons must assess the vascular supply of the donor site. The "expansion footprint" must be calculated to ensure sufficient skin is generated.
  • Informed Consent: Patients must understand the multi-stage nature of the treatment, the aesthetic appearance of the expander during the inflation phase, and the potential for device-related complications.
  • Baseline Imaging: Documentation of the defect size and surrounding tissue quality.

5. Detailed Procedure: The Surgical Intervention

Step 1: Incision Planning

The incision is typically placed at the junction of the healthy skin and the scar or defect, or within a pre-existing scar to hide future markings. It must be designed to allow for the future transposition of the expanded flap.

Step 2: Pocket Dissection

The surgeon creates a sub-muscular or sub-fascial pocket. Sub-muscular placement (e.g., in breast reconstruction) provides better soft-tissue coverage and reduces the risk of expander extrusion.

Step 3: Placement and Hemostasis

The expander is inserted in a collapsed state. The device is checked for leaks before final closure. Meticulous hemostasis is vital, as a hematoma can lead to infection and subsequent loss of the expander.

Step 4: Port Placement

If using a remote port, it is sutured to the underlying fascia to prevent migration, ensuring it is palpable for future injections.

Step 5: Closure

The incision is closed in layers to minimize tension on the wound edges, which is the primary cause of dehiscence.


6. Post-Operative Recovery and Expansion Protocol

The Recovery Phase

  • Days 1–14: Focus on wound healing. Minimal activity involving the affected area is encouraged.
  • Expansion Initiation: Usually begins 2–3 weeks post-op, once the incision is fully epithelialized and stable.

The Expansion Schedule

Injections are performed in the clinic under sterile conditions.
1. Preparation: The skin over the port is cleansed with Betadine or Chlorhexidine.
2. Injection: Sterile saline is injected via a 21-25 gauge needle.
3. Volume: Incremental expansion is typically performed weekly or bi-weekly. The volume is titrated based on patient comfort and skin blanching.


7. Risks, Side Effects, and Contraindications

Potential Complications

  • Infection: The most common cause of expander loss. Requires immediate systemic antibiotics and often removal of the device.
  • Expander Exposure/Extrusion: Usually occurs at the suture line due to excessive tension or delayed healing.
  • Deflation: Rare, but can occur due to port leakage or needle puncture of the shell.
  • Pain/Discomfort: During rapid expansion; managed with over-the-counter analgesics or temporary cessation of expansion.

Contraindications

  • Active Infection: Absolute contraindication at the site.
  • Severe Peripheral Vascular Disease: Compromised blood supply limits the tissue's ability to stretch safely.
  • Radiation Therapy: Irradiated skin has poor elasticity and vascularity; expansion in these areas has a high failure rate.

8. Alternative Treatments

  • Free Tissue Transfer (Flaps): Bringing skin, fat, and muscle from a distant site (e.g., DIEP flap).
  • Skin Grafting: Using split-thickness or full-thickness grafts. Often inferior in color/texture match.
  • Dermal Substitutes: Bioengineered matrices used to support wound healing, often in conjunction with negative pressure wound therapy.

9. FAQ: Frequently Asked Questions

1. Does the expansion process hurt?
Most patients describe a sensation of "tightness" or pressure rather than sharp pain. If pain becomes severe, the expansion rate is slowed.

2. How long does the entire process take?
Depending on the area and the amount of skin needed, the expansion phase typically lasts 8 to 16 weeks.

3. What happens if the expander leaks?
A deflated expander is usually easily diagnosed by a change in the shape of the site. It must be replaced surgically.

4. Can I exercise with a tissue expander?
Light activity is encouraged, but heavy lifting or exercises that place direct tension on the expander site should be avoided until cleared by the surgeon.

5. Is the new skin permanent?
Yes. Once the expansion is complete and the flap is transposed, the new skin maintains its expanded surface area.

6. Will I have a scar?
Yes, but the goal is to position the scar along natural skin creases or within previous incision lines to minimize visibility.

7. How much saline is injected at one time?
This varies by the size of the device and the patient's tissue tolerance. Usually, 10% to 20% of the expander's total volume is added per session.

8. Can children undergo tissue expansion?
Yes, it is frequently used in pediatric cases to treat congenital nevi or burn scars, as the expanded skin grows with the child.

9. Is the procedure covered by insurance?
In most cases of reconstructive surgery (such as post-mastectomy or post-burn), tissue expansion is covered as a medically necessary procedure.

10. What is the success rate?
In the hands of an experienced reconstructive surgeon, the success rate for tissue expansion is very high (typically >90%), though patient compliance with follow-up appointments is critical.


10. Summary for Clinical Practitioners

Tissue expander insertion remains a gold-standard technique for creating high-quality, autologous donor tissue. While the procedure requires patience from both the surgeon and the patient, the ability to achieve a functional and aesthetic match that is virtually impossible with other methods justifies the extended timeline. Success is predicated on meticulous surgical technique, careful management of the expansion schedule, and early intervention at the first sign of wound healing complications.

Share this procedure: